RT Journal Article
SR Electronic
T1 Do low TB prevalence and lack of BCG Vaccinations Contribute to Emergence of Multisystem Inflammatory Syndrome in Children?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.18.20156893
DO 10.1101/2020.07.18.20156893
A1 Tareef Fadhil Raham
YR 2020
UL http://medrxiv.org/content/early/2020/07/29/2020.07.18.20156893.abstract
AB Background Emergence of new multisystem inflammatory syndrome in children (MIS-C) is thought to be associated with COVID-19 pandemic. Covid-19 morbidity and mortality variances among countries have been suggested by previous works to be influenced by BCG and previous latent TB infection (which is reflected by TB prevalence) possibly through inducing heterogeneous immunity against SARS-CoV-2.Aim To examine influence of BCG status and TB prevalence on variances among countries which report new multisystem inflammatory syndrome in children (MIS-C).Methods We choose all countries which report MIS-C till 23/6/2020, number of cases for each 10 million inhabitants was examined among 3 categories of countries classified according to BCG program status. TB prevalence, MIS-C no. / 10 million (M) population and Covid-19 deaths/M are taken as markers. Receiver operation characteristic - (ROC) curve, with some relative indicators such as (sensitivity and specificity rates), estimation area of trade - off between sensitivity and specificity, and cutoff points are used with different studied markers for discriminating different three pairs of countries (which have different BCG practices).Results MIS-C No/10 M inhabitants in countries never gave BCG vaccination versus (vs) countries currently give vaccine shows area under ROC-curve equal to 0.000 with a symbiotic significant of 0.034 and (95% CI interval of 0.000-0.000) also MIS-C No/10 M inhabitants in countries not currently give BCG vaccination (with previous mass vaccination programs) vs countries currently give mass vaccination shows area under ROC-curve equal to 0.094 with a symbiotic significant of 0.027and (95% CI interval of 0.000 -0.280).Important not significant finding MIS-C No/10 M inhabitants in countries never gave BCG vaccination vs countries not currently give vaccine shows area under ROC-curve equal to 0.583 with a symbiotic significant of 0.683 and (95% CI interval of 0.074-0.759).COVID-19 deaths / M inhabitants in countries never gave BCG vaccination vs countries currently give vaccine show area under ROC-curve equal to 0.083 with a symbiotic informative and reportable value of 0.077 and (95% CI interval of 0.000-0.309 also COVID-19 deaths/ M inhabitants in countries not currently give BCG vaccination vs countries currently giving vaccine show area under ROC-curve equal to 0.188 with a symbiotic informative reportable value of 0.089 and (95% CI interval of 0.000-0.452).Important finding is the not significant association of COVID-19 deaths /M inhabitants with countries never gave BCG vaccination vs countries not currently giving vaccine area under ROC-curve equal to 0.417 with a symbiotic significant of 0.683 and (95% CI interval of 0.078 - 0.755).Regarding TB prevalence marker or discriminator the areas under curve were informative and reportable and too generating with the leftover markers in all 3 pairs of countries signifying inverse relations with covide-19 mortality and MIS-C no.Conclusions BCG vaccinations and high TB prevalence are found to be related to decrease MIS-C no. and COVID-19 deaths this might explain variances among countries worldwide. Further studies to confirm this relation and to confirm possible similar relations in Kawasaki disease(KD) or KD like illnesses in previous epidemics is recommended. Review of TB programs and consolidation of BCG programs might be considered urgently.Strengths and limitations of this studyTo our knowledge, this study will be the first addressing TB prevalence status influence on MIS-C incidence in countries with different BCG vaccination status practices.This study also will address disparities raised regarding variances in incidence of MIS-C and COVID-19 deaths rates among countries.This study discusses possible relation of KD or KD like illnesses with previous pandemics according to various TB prevalence of some countries.Potential confounding factors still exist.Another limitation is that this study is done in mid of COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data used are publicAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are available on requist